Dr. Meghen B. Browning
Claim this profileChildren's Hospital of Wisconsin
Studies Tumors
Studies Neuroblastoma
16 reported clinical trials
40 drugs studied
Area of expertise
1Tumors
Stage I
Stage IV
Stage II
2Neuroblastoma
Stage IV
MYC positive
MYC negative
Affiliated Hospitals
Clinical Trials Meghen B. Browning is currently running
DFMO + Etoposide
for Neuroblastoma
This trial uses two drugs, DFMO and etoposide, to treat children whose neuroblastoma has come back or didn't respond to initial treatments. DFMO stops cancer cells from growing, and etoposide helps kill them. The study includes patients who are recovering after additional therapy, those who have had the disease return but are currently without symptoms, and those with active disease. DFMO has been evaluated as a follow-up treatment for severe neuroblastoma in previous studies.
Recruiting1 award Phase 2
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Meghen B. Browning
Clinical Trial Related18 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Meghen B. Browning has experience with
- Cyclophosphamide
- Carboplatin
- Etoposide
- Vinorelbine
- Ramucirumab
- Cisplatin
Breakdown of trials Meghen B. Browning has run
Tumors
Neuroblastoma
Cancer
Ganglioneuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Meghen B. Browning specialize in?
Meghen B. Browning focuses on Tumors and Neuroblastoma. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Meghen B. Browning currently recruiting for clinical trials?
Yes, Meghen B. Browning is currently recruiting for 6 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Meghen B. Browning has studied deeply?
Yes, Meghen B. Browning has studied treatments such as Cyclophosphamide, Carboplatin, Etoposide.
What is the best way to schedule an appointment with Meghen B. Browning?
Apply for one of the trials that Meghen B. Browning is conducting.
What is the office address of Meghen B. Browning?
The office of Meghen B. Browning is located at: Children's Hospital of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Children's Hospital of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.